[Does transurethral resection cause metastatic dissemination of hormone treated prostatic cancer?].

Autor: Morote Robles J; Servicio de Urología, Hospital General Valle de Hebrón, Barcelona., Reig Ruiz C, Vila Barja J, Lorente Garin JA, López Pacios MA, de Torres Mateos JA, Soler Roselló A
Jazyk: Spanish; Castilian
Zdroj: Actas urologicas espanolas [Actas Urol Esp] 1993 Mar; Vol. 17 (3), pp. 187-9.
Abstrakt: The evolution of non-metastatic prostate cancer treated with hormonal therapy does not appear to be affected by the performance of a transurethral resection (TUR) as a measure to expedite the common urinary tract. Of 82 patients followed for an interval ranging from 6 months to 15 years, 3 of 45 patients (6.7%) undergoing RUT experienced metastatic dissemination, while the same happened in 2 of 37 (5.4%) patients who did not undergo RUT, p being NS. The group of patients requiring RUT, however, experienced higher local progression rates, 22.2% vs 5.4%, a situation not ascribable to the RUT procedure but to the fact that such surgery was selectively indicated in neoplasias with larger tumoral mass.
Databáze: MEDLINE